Skip to main content
Premium Trial:

Request an Annual Quote

Life Tech, Boston Children's Hospital to Develop Sequencing Workflows on Ion Proton in CLIA Lab

NEW YORK (GenomeWeb News) – Life Technologies said today that it will collaborate with Boston Children's Hospital to develop next-generation sequencing workflows in a CLIA and CAP certified laboratory.

As part of the collaboration, the hospital plans to purchase Life Tech's Ion Proton, a benchtop, semiconductor sequencing machine.

David Margulies, director of the Gene Partnership Program at Boston Children's Hospital, said in statement that the deal is an "important first step toward providing informed, personalized care for patients whose conditions are difficult to treat."

The deal is Life Tech's second announced this week to develop sequencing protocols for the Ion Proton in collaboration with a children's hospital. Earlier this week, it said it would work with the Hospital for Sick Children in Toronto, which has launched a new Centre for Genetic Medicine and plans to install four Proton machines.

Paul Billings, Life Tech's chief medical officer, commented in a statement that these kinds of partnerships are "essential to our medical sciences strategy as we seek to assist researchers in discovering improved diagnostics and treatments for genetic conditions."

In a separate announcement today, Life Tech said that it is collaborating with the University of North Texas Health Science Center's Institute of Applied Genetics to use the firm's Ion Personal Genome Machine system to further the center's forensic DNA research. Life Tech said that it will collaborate with the center to train forensic analysts in applying next-gen sequencing to their research.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.